Provided by Tiger Fintech (Singapore) Pte. Ltd.

CytomX Therapeutics

0.5003
+0.04529.93%
Post-market: 0.52620.0259+5.18%19:56 EDT
Volume:1.50M
Turnover:730.15K
Market Cap:40.07M
PE:1.33
High:0.5200
Open:0.4600
Low:0.4300
Close:0.4551
Loading ...
Mar 23, 2020

Major Issues Report

Current report, item 5.02
Mar 06, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 27, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 27, 2020

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Feb 20, 2020

Major Issues Report

Current report, item 5.02
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 11, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 05, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 31, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jan 27, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Nov 07, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Aug 29, 2019

Major Issues Report

Current report, item 5.02
Aug 22, 2019

Major Issues Report

Current report, item 5.02
Aug 07, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Aug 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Jun 21, 2019

Major Issues Report

Current report, item 5.07
Jun 21, 2019

Major Issues Report

[Amend] Current report, item 5.02